Cullinan Therapeutics, Inc.·4

Dec 22, 5:00 PM ET

Michaelson Jennifer 4

4 · Cullinan Therapeutics, Inc. · Filed Dec 22, 2025

Insider Transaction Report

Form 4
Period: 2025-12-19
Michaelson Jennifer
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2025-12-19$10.01/sh1,345$13,463132,635 total
Footnotes (2)
  • [F1]Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.99 to $10.09. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4